Emprise Bank reduced its stake in TE Connectivity Ltd. (NYSE:TEL – Free Report) by 1.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,896 shares of the electronics maker’s stock after selling 74 shares during the period. Emprise Bank’s holdings in […]

Reyes Financial Architecture Inc. boosted its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 972 shares of the medical research company’s stock after purchasing an additional 132 shares during the period. Reyes […]

Central Bank & Trust Co. cut its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,544 shares of the medical research company’s stock after selling 217 shares during the period. Amgen […]

Reyes Financial Architecture Inc. boosted its holdings in shares of Visa Inc. (NYSE:V – Free Report) by 13.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,837 shares of the credit-card processor’s stock after purchasing an additional 220 shares during the quarter. Reyes […]

Czech National Bank grew its stake in Chevron Corporation (NYSE:CVX – Free Report) by 3.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 396,970 shares of the oil and gas company’s stock after purchasing an additional 13,100 shares during the period. Czech […]

Hickory Point Bank & Trust lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 6.0% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 15,487 shares of the biopharmaceutical company’s stock after selling 997 shares during the quarter. Hickory Point Bank & Trust’s holdings in Pfizer were worth $375,000 as […]

Central Bank & Trust Co. lowered its position in shares of McKesson Corporation (NYSE:MCK – Free Report) by 1.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,983 shares of the company’s stock after selling 31 shares during the quarter. Central Bank & Trust Co.’s holdings […]

St. Louis Financial Planners Asset Management LLC acquired a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 18,301 shares of the healthcare product maker’s stock, valued at approximately $2,489,000. Abbott Laboratories […]

Central Bank & Trust Co. cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.0% during the 2nd quarter, HoldingsChannel reports. The firm owned 2,068 shares of the biopharmaceutical company’s stock after selling 64 shares during the quarter. Central Bank & Trust Co.’s holdings in Regeneron Pharmaceuticals were worth $1,086,000 at the […]